Posted on September 08, 2022
The moves come as Genome Medical has brought on new customers. Invitae Corp. (NYSE: NVTA) had shifted some of its genetic testing work to Genome Medical after that genetic testing pioneer this summer decided to cut 1,000 jobs and realign operations, the bulk of those job losses coming in San Francisco.